View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
TUESDAY, April 28 (HealthDay News) -- In response to the threat of a swine flu epidemic, the U.S. Food and Drug Administration has issued an Emergency Use Authorization (EUA) to permit broader use of the antiviral medications zanamivir (Relenza) and oseltamivir (Tamiflu), and the use of the rRT-PCR Swine Flu Panel diagnostic test.
The EUA will enable medical authorities to distribute the medications to large segments of the population without complying with the label requirements. They also may be distributed by a broader range of health care workers, including some public health officials and volunteers, as part of the emergency response. The EUA also permits the use of Tamiflu in children under 1 year old, contrary to the current FDA-approved dosing, and provides alternate dosing recommendations for children older than 1 year.
The FDA said the EUA for the rRT-PCR Swine Flu Panel diagnostic test was based on the determination that it may be effective in testing samples from individuals with influenza A, whose virus cannot be identified by current tests. The EUA allows the specialized swine flu test to be distributed to public health and qualified laboratories that have the appropriate equipment and personnel.
The emergency authorization came at the request of the U.S. Centers for Disease Control and Prevention to make the diagnostic and therapeutic tools available to public health and medical personnel should circumstances warrant in the fast-moving outbreak. Health care professionals and consumers can report serious side effects or product quality problems to the FDA's MedWatch Adverse Event Reporting program by regular mail (MedWatch, 5600 Fishers Lane, Rockville, Md. 20852-9787), fax (800-FDA-0178), phone (800-FDA-1088), or online.
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top